ChitaLabs
World's Only Cleanroom-Based Clinical Specimen Analysis
MFDS-designated GCLP-certified analysis institution. Blood biomarker measurement down to attomolar (aM) levels using SIMOA, NULISA, and ELISA.
GCLP Certified
Cleanroom-Based Analytical Infrastructure
We conduct clinical trial specimen analysis meeting GCLP certification standards in Korea's first cleanroom environment, guaranteeing world-class analytical accuracy, reproducibility, and full ICH international standard compliance.
- MFDS-designated GCLP institution
- Cleanroom environment (Korea-exclusive)
- Full ICH guideline compliance
- 65,000+ cumulative analyses
- Asia's largest blood biomarker analysis experience
The Difference in Quality
Same Instrument, Different Results
SIMOA result quality varies greatly with environment and SOP. With Bredis Healthcare's optimized SOP and cleanroom environment, you get clean, uniform results, while typical environments can yield contamination and defects.
Clean, uniform signal
Contamination & defects reduce reliability
Analysis Services
State-of-the-Art Analysis Platforms
NULISA™ Assays
Official Alamar Biosciences Partnership — Hundreds of biomarkers simultaneously
NULISA™ analysis on the ARGO™ HT System enables simultaneous quantification of hundreds of proteins at fg/mL sensitivity from just 50 μL of sample, combining antibody-oligonucleotide complexes with NGS sequencing.
- Hundreds of simultaneous biomarkers
- Minimal sample volume: 50 μL
- fg/mL ultra-sensitive detection
- Antibody-oligo complexes + NGS
- Research-to-clinical scalability
Simoa® HD-X Analyzer™
Next-gen immunoassay based on single-molecule array technology
Enables fg/mL-level protein quantitation — 1,000× more sensitive than ELISA. Operated exclusively in a cleanroom environment in Korea, with ICH-compliant SOPs and a dedicated expert team.
- fg/mL protein quantification
- 1,000× more sensitive than ELISA
- Cleanroom operation (Korea-exclusive)
- ICH guideline-compliant SOPs
- Dedicated expert team
ELISA Analysis Service
96-well plate-based validated immunoassay
Enzyme-linked immunosorbent assay broadly applied from basic research to diagnostic medicine and biologics QC. Cytokines, hormones, and neurological biomarkers analyzed in a cleanroom environment per ICH international standards.
- 96-well plate format
- Cleanroom analysis environment
- ICH international standards
- Cytokines, hormones, neuro biomarkers
- Basic research to clinical applications
Custom Assay Development
Tailored assay development for trace proteins undetectable by conventional methods
Assay development and validation tailored to researchers' specific requirements. A two-phase systematic process from feasibility testing through optimization and validation delivers ICH-compliant, high-quality assays.
- Phase 1: Feasibility & reagent preparation
- Phase 2: Optimization & ICH validation
- Custom protocol development
- Final analytical report delivery
- Research-to-clinical transition support
Measured Targets
Key Brain Disease Biomarkers
Custom biomarker support available upon request
ChitaLabs Customer Portal
ChitaLabs Analysis Customer Portal
When automated instruments finish sample preparation and analysis, results are transmitted to the database and auto-compiled into reports viewable in your account. By removing manual steps, human error is minimized — and every stage from order to result is tracked in real time in one place.
Automated Reporting
Results are sent to the database the moment analysis ends and auto-compiled into reports in your account.
Minimized Human Error
Preparation, analysis, and recording are linked in one automated pipeline, reducing manual mistakes.
Real-Time Tracking
Check order status, sample collection/storage, and analysis progress in real time.
Unified History
Review past analysis results all at once for systematic data management.
crms.bredis.co.kr
Considering Our Analysis Services?
We offer free consultations on scope, timeline, and pricing.
Request Free Consultation →